{"entity":{"type":"insider","cik":"0001263501","url":"/insider/0001263501","json_url":"/insider/0001263501.json","name":"SHALLCROSS STEVEN A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":23,"first":"2006-12-13","last":"2023-06-08","span_basis":"filed_date"},"name_variants":[{"name":"SHALLCROSS STEVEN A","source":"filing","n_filings":23,"first_seen":"2006-12-13","last_seen":"2023-06-08"}],"transactions":[{"id":7925010,"accession":"0001104659-23-069136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-069136","line_url":"/filing/0001104659-23-069136#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Theriva Biologics, Inc.","issuer_ticker":"TOVX","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":0.6931,"price_display":"0.69","price_state":"stated","total_value":9703.4,"total_display":"9,703.40","total_whole":"9,703","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-08","scope":"insider"},{"id":8290409,"accession":"0001104659-23-068719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-068719","line_url":"/filing/0001104659-23-068719#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Theriva Biologics, Inc.","issuer_ticker":"TOVX","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":0.6328,"price_display":"0.63","price_state":"stated","total_value":16452.8,"total_display":"16,452.80","total_whole":"16,453","shares_owned_after":236000.0,"shares_owned_after_display":"236,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":8533583,"accession":"0001104659-23-018901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-018901","line_url":"/filing/0001104659-23-018901#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Theriva Biologics, Inc.","issuer_ticker":"TOVX","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.043,"price_display":"1.04","price_state":"stated","total_value":26075.0,"total_display":"26,075.00","total_whole":"26,075","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-13","scope":"insider"},{"id":8697031,"accession":"0001104659-23-010108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-010108","line_url":"/filing/0001104659-23-010108#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Theriva Biologics, Inc.","issuer_ticker":"TOVX","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.9405,"price_display":"0.94","price_state":"stated","total_value":23512.5,"total_display":"23,512.50","total_whole":"23,513","shares_owned_after":185000.0,"shares_owned_after_display":"185,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider"},{"id":8052015,"accession":"0001104659-23-006677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-006677","line_url":"/filing/0001104659-23-006677#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Theriva Biologics, Inc.","issuer_ticker":"TOVX","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.873,"price_display":"0.87","price_state":"stated","total_value":21825.0,"total_display":"21,825.00","total_whole":"21,825","shares_owned_after":160000.0,"shares_owned_after_display":"160,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-26","scope":"insider"},{"id":8429029,"accession":"0001104659-23-005546","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-005546","line_url":"/filing/0001104659-23-005546#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Theriva Biologics, Inc.","issuer_ticker":"TOVX","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.7482,"price_display":"0.75","price_state":"stated","total_value":18705.0,"total_display":"18,705.00","total_whole":"18,705","shares_owned_after":135000.0,"shares_owned_after_display":"135,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":8725941,"accession":"0001104659-23-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-000023","line_url":"/filing/0001104659-23-000023#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Theriva Biologics, Inc.","issuer_ticker":"TOVX","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.437,"price_display":"0.44","price_state":"stated","total_value":43700.0,"total_display":"43,700.00","total_whole":"43,700","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2023-01-03","scope":"insider"},{"id":4843542,"accession":"0001104659-21-064047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-064047","line_url":"/filing/0001104659-21-064047#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.4919,"price_display":"0.49","price_state":"stated","total_value":24595.0,"total_display":"24,595.00","total_whole":"24,595","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-10","filed_date":"2021-05-10","scope":"insider"},{"id":8524009,"accession":"0001144204-19-041677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-041677","line_url":"/filing/0001144204-19-041677#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Director, Officer (CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.4157,"price_display":"0.42","price_state":"stated","total_value":20785.0,"total_display":"20,785.00","total_whole":"20,785","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-26","scope":"insider"},{"id":6970489,"accession":"0001144204-14-052580","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-052580","line_url":"/filing/0001144204-14-052580#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27500.0,"shares_display":"27,500","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":10450.0,"total_display":"10,450.00","total_whole":"10,450","shares_owned_after":79500.0,"shares_owned_after_display":"79,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-26","filed_date":"2014-08-27","scope":"insider"},{"id":6740391,"accession":"0001144204-14-051964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-051964","line_url":"/filing/0001144204-14-051964#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52000.0,"shares_display":"52,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":20280.0,"total_display":"20,280.00","total_whole":"20,280","shares_owned_after":52000.0,"shares_owned_after_display":"52,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-21","scope":"insider"},{"id":8458995,"accession":"0001209191-07-067007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-067007","line_url":"/filing/0001209191-07-067007#line-3","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":29700.0,"total_display":"29,700.00","total_whole":"29,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-28","filed_date":"2007-11-30","scope":"insider"},{"id":7137441,"accession":"0001209191-07-058896","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-058896","line_url":"/filing/0001209191-07-058896#line-3","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":17.93,"price_display":"17.93","price_state":"stated","total_value":59169.0,"total_display":"59,169.00","total_whole":"59,169","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-16","filed_date":"2007-10-18","scope":"insider"},{"id":7594624,"accession":"0001209191-07-054467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-054467","line_url":"/filing/0001209191-07-054467#line-3","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":14.81,"price_display":"14.81","price_state":"stated","total_value":48873.0,"total_display":"48,873.00","total_whole":"48,873","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-18","filed_date":"2007-09-20","scope":"insider"},{"id":8085095,"accession":"0001209191-07-050255","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-050255","line_url":"/filing/0001209191-07-050255#line-3","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":15.21,"price_display":"15.21","price_state":"stated","total_value":50193.0,"total_display":"50,193.00","total_whole":"50,193","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-21","filed_date":"2007-08-23","scope":"insider"},{"id":7273375,"accession":"0001209191-07-043236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-043236","line_url":"/filing/0001209191-07-043236#line-2","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":20.63,"price_display":"20.63","price_state":"stated","total_value":68079.0,"total_display":"68,079.00","total_whole":"68,079","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-17","filed_date":"2007-07-19","scope":"insider"},{"id":7538837,"accession":"0001209191-07-038349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-038349","line_url":"/filing/0001209191-07-038349#line-2","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":21.19,"price_display":"21.19","price_state":"stated","total_value":69927.0,"total_display":"69,927.00","total_whole":"69,927","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-19","filed_date":"2007-06-21","scope":"insider"},{"id":6854099,"accession":"0001209191-07-031060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-031060","line_url":"/filing/0001209191-07-031060#line-2","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":19.39,"price_display":"19.39","price_state":"stated","total_value":63987.0,"total_display":"63,987.00","total_whole":"63,987","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-15","filed_date":"2007-05-17","scope":"insider"},{"id":8162831,"accession":"0001209191-07-024509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-024509","line_url":"/filing/0001209191-07-024509#line-2","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":21.58,"price_display":"21.58","price_state":"stated","total_value":71214.0,"total_display":"71,214.00","total_whole":"71,214","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-17","filed_date":"2007-04-19","scope":"insider"},{"id":8323617,"accession":"0001209191-07-019099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-019099","line_url":"/filing/0001209191-07-019099#line-2","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":23.08,"price_display":"23.08","price_state":"stated","total_value":76164.0,"total_display":"76,164.00","total_whole":"76,164","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-20","filed_date":"2007-03-21","scope":"insider"},{"id":8162147,"accession":"0001209191-07-011967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-011967","line_url":"/filing/0001209191-07-011967#line-2","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":27.37,"price_display":"27.37","price_state":"stated","total_value":90321.0,"total_display":"90,321.00","total_whole":"90,321","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-20","filed_date":"2007-02-20","scope":"insider"},{"id":7194129,"accession":"0001209191-07-004172","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-07-004172","line_url":"/filing/0001209191-07-004172","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":25.3301875,"price_display":"25.33","price_state":"stated","total_value":81056.6,"total_display":"81,056.60","total_whole":"81,057","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-01-16","filed_date":"2007-01-18","scope":"insider","n_lines":12},{"id":3855220,"accession":"0001209191-06-064572","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-064572","line_url":"/filing/0001209191-06-064572#line-2","is_derivative":false,"issuer_cik":"0001263501","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001263501","owner_cik":"0001263501","owner_name":"SHALLCROSS STEVEN A","owner_display_name":"SHALLCROSS STEVEN A","owner_url":"/insider/0001263501","role":"Officer (Sr. VP, CFO, Treasurer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, CFO, Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, CFO, Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.45,"price_display":"26.45","price_state":"stated","total_value":264500.0,"total_display":"264,500.00","total_whole":"264,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-11","filed_date":"2006-12-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000894158","name":"Theriva Biologics, Inc.","url":"/issuer/0000894158","role":"Director, Officer (CEO and CFO)","n_filings":9,"first_seen":"2019-08-26","last_seen":"2023-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001091596","name":"CYTOMEDIX INC","url":"/issuer/0001091596","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2014-08-21","last_seen":"2014-08-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (Sr. VP, CFO, Treasurer)","n_filings":12,"first_seen":"2006-12-13","last_seen":"2007-11-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001263501","retrieved_at":"2026-08-24T04:12:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}